The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Speirs, K.
Right arrow Articles by Scott, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Speirs, K.
Right arrow Articles by Scott, P.
The Journal of Immunology, 2004, 172: 752-756.
Copyright © 2004 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: NF-{kappa}B2 Is a Negative Regulator of Dendritic Cell Function1

Kendra Speirs*, Linda Lieberman*, Jorge Caamano{dagger}, Christopher A. Hunter* and Phillip Scott2,*

* Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104; and {dagger} Medical Research Council Centre for Immune Regulation, School of Medicine, University of Birmingham, Edgbaston, Birmingham, United Kingdom

RelB, a member of the NF-{kappa}B family of transcription factors, is essential for dendritic cell (DC) maturation. Recent findings indicate that RelB is exclusively regulated through its interaction with cytoplasmic NF-{kappa}B2/p100. The studies presented in this report show that DCs lacking NF-{kappa}B2 have dramatically enhanced RelB activity, associated with increased MHC class II and costimulatory molecule expression and an enhanced ability to induce CD4+ T cell responses. These studies identify a novel role for NF-{kappa}B2 in the negative regulation of RelB-induced DC maturation, with critical consequences for the regulation of adaptive immune responses.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. F. Lind, C. L. Ahonen, A. Wasiuk, Y. Kosaka, B. Becher, K. A. Bennett, and R. J. Noelle
Dendritic Cells Require the NF-{kappa}B2 Pathway for Cross-Presentation of Soluble Antigens
J. Immunol., July 1, 2008; 181(1): 354 - 363.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pepper, F. Dzierszinski, E. Wilson, E. Tait, Q. Fang, F. Yarovinsky, T. M. Laufer, D. Roos, and C. A. Hunter
Plasmacytoid Dendritic Cells Are Activated by Toxoplasma gondii to Present Antigen and Produce Cytokines
J. Immunol., May 1, 2008; 180(9): 6229 - 6236.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Vaira, T. Johnson, A. C. Hirbe, M. Alhawagri, I. Anwisye, B. Sammut, J. O'Neal, W. Zou, K. N. Weilbaecher, R. Faccio, et al.
RelB is the NF-{kappa}B subunit downstream of NIK responsible for osteoclast differentiation
PNAS, March 11, 2008; 105(10): 3897 - 3902.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Legarda-Addison and A. T. Ting
Negative Regulation of TCR Signaling by NF-{kappa}B2/p100
J. Immunol., June 15, 2007; 178(12): 7767 - 7778.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wang, X. Wang, S. Hussain, Y. Zheng, S. Sanjabi, F. Ouaaz, and A. A. Beg
Distinct Roles of Different NF-{kappa}B Subunits in Regulating Inflammatory and T Cell Stimulatory Gene Expression in Dendritic Cells
J. Immunol., June 1, 2007; 178(11): 6777 - 6788.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Moore, S. Buonocore, E. Aksoy, N. Ouled-Haddou, S. Goriely, E. Lazarova, F. Paulart, C. Heirman, E. Vaeremans, K. Thielemans, et al.
An Alternative Pathway of NF-{kappa}B Activation Results in Maturation and T Cell Priming Activity of Dendritic Cells Overexpressing a Mutated I{kappa}B{alpha}
J. Immunol., February 1, 2007; 178(3): 1301 - 1311.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Jorgl, B. Platzer, S. Taschner, L. X. Heinz, B. Hocher, P. M. Reisner, F. Gobel, and H. Strobl
Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB
Blood, January 1, 2007; 109(1): 185 - 193.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. M. Tato, N. Mason, D. Artis, S. Shapira, J. C. Caamano, J. H. Bream, H.-C. Liou, and C. A. Hunter
Opposing roles of NF-{kappa}B family members in the regulation of NK cell proliferation and production of IFN-{gamma}
Int. Immunol., April 1, 2006; 18(4): 505 - 513.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. J. Cejas, L. M. Carlson, D. Kolonias, J. Zhang, I. Lindner, D. D. Billadeau, L. H. Boise, and K. P. Lee
Regulation of RelB Expression during the Initiation of Dendritic Cell Differentiation
Mol. Cell. Biol., September 1, 2005; 25(17): 7900 - 7916.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Pepper, F. Dzierszinski, A. Crawford, C. A. Hunter, and D. Roos
Development of a System To Study CD4+-T-Cell Responses to Transgenic Ovalbumin-Expressing Toxoplasma gondii during Toxoplasmosis
Infect. Immun., December 1, 2004; 72(12): 7240 - 7246.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.